V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190006853 | 190004300 | 1.71 | 86.8 | Palliative (P) | 2021-06-29 | 2021-07-10 | NB HRNBL-1 Isotretinoin | 02 | N | CARBOPLATIN + VINORELBINE | 101813862 |
| 190006855 | 190004301 | 1.84 | 57 | Palliative (P) | 2017-11-15 | 2018-04-24 | Epirubicin (weekly) | null | Y | DOCETAXEL | 101250750 |
| 190006866 | 190004302 | 1.76 | 75 | 01 | 2017-04-27 | 2017-08-28 | CAPECITABINE + CARBOPLATIN | 02 | Y | DOXORUBICIN + OLARATUMAB | 101075297 |
| 190006869 | 190004303 | 1.64 | 92.4 | Curative (C) | 2016-07-10 | 2016-07-10 | PEMBROLIZUMAB | 02 | N | CARBOPLATIN + ETOPOSIDE | 101142086 |
| 190006870 | 190004304 | 1.8 | 42.1 | Curative (C) | 2018-12-10 | 2018-12-25 | CARBOPLATIN + RT | 02 | N | CISPLATIN + RT | 101102225 |
| 190006876 | 190004305 | 1.67 | 107 | Curative (C) | 2019-06-19 | 2019-12-20 | Cisplatin + Radiotherapy | 01 | N | CISPLATIN | 101077748 |
| 190006879 | 190004306 | null | 54.5 | Curative (C) | 2017-01-13 | 2017-01-21 | Cisplatin + Etoposide (5 day) | Y | N | GEMCITABINE | 100034127 |
| 190006880 | 190004307 | 1.84 | 76.7 | null | 2020-04-18 | 2020-11-09 | Capecitabine | 2 | Y | FLUOROURACIL + IRINOTECAN | 100352964 |
| 190006887 | 190004308 | 1.6 | 95 | null | 2017-08-19 | 2017-11-09 | OCTREOTIDE | 02 | N | CAPECITABINE + OXALIPLATIN | 100625828 |
| 190006891 | 190004309 | 1.49 | 20 | null | null | 2017-04-20 | Cisplatin 7 day | null | null | CISPLATIN | 101311680 |
| 190006895 | 190004310 | 1.73 | 56.1 | Neo-adjuvant (N) | 2019-08-07 | 2019-08-07 | TEMOZOLOMIDE | 02 | N | FLUOROURACIL + OXALIPLATIN | 100644335 |
| 190006897 | 190004311 | 1.79 | 91.8 | Curative (C) | 2020-09-23 | 2020-09-23 | Bevacizumab 7.5mg/kg | 02 | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100842510 |
| 190006898 | 190004312 | 1.6 | 64.5 | null | 2017-08-04 | 2017-08-07 | EW EuroEwing 2012 Arm B VDC/IE | null | null | CISPLATIN + GEMCITABINE | 101712562 |
| 190006902 | 190004313 | 1.58 | 87.2 | Palliative (P) | 2020-02-07 | 2020-02-21 | CARBOPLATIN + PACLITAXEL | 02 | Y | CARBOPLATIN + PACLITAXEL | 100656991 |
| 190006919 | 190004314 | 0 | 20.4 | Palliative (P) | 2019-11-05 | 2019-11-20 | CARBOPLATIN + PACLITAXEL | Y | N | CARBOPLATIN + PACLITAXEL | 101018181 |
| 190006922 | 190004315 | null | 67.4 | null | 2016-03-24 | 2016-03-28 | EW Rel rEECur Irinotecan/Temozolomide | 02 | null | TEMOZOLOMIDE | 101096842 |
| 190006923 | 190004316 | 1.64 | 70 | Palliative (P) | 2016-05-15 | 2016-06-13 | Bevacizumab 7.5mg/kg | 02 | null | TOPOTECAN | 101679873 |
| 190006927 | 190004317 | 1.61 | 11.2 | Curative (C) | 2008-01-31 | 2018-04-17 | Carboplatin + Docetaxel | Y | N | CARBOPLATIN + GEMCITABINE | 100395443 |
| 190006929 | 190004318 | 1.56 | 52 | Curative (C) | 2015-09-05 | 2015-11-01 | Avelumab | Y | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101030233 |
| 190006949 | 190004319 | 1.56 | 78.5 | null | 2016-09-10 | 2016-12-18 | EW EuroEwing 2012 Arm B VDC | N | N | CAPECITABINE + TEMOZOLOMIDE | 100485834 |
| 190006959 | 190004320 | 1.72 | 63.5 | Palliative (P) | null | 2017-12-09 | Cyclophosphamide oral | 02 | N | LIPOSOMAL DOXORUBICIN | 100858620 |
| 190006961 | 190004321 | 1.81 | 23.6 | null | 2019-07-15 | 2019-07-16 | Ifosfamide | 02 | N | CISPLATIN + GEMCITABINE | 101243207 |
| 190006963 | 190004322 | 1.83 | 67.1 | Curative (C) | 2016-08-26 | 2016-09-02 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100403203 |
| 190006964 | 190004323 | 1.69 | 65.8 | null | 2021-04-03 | 2021-05-30 | EW Rel rEECur Gemcitabine/Docetaxel | 02 | N | EVEROLIMUS | 100348099 |
| 190006966 | 190004324 | 1.74 | 84.7 | Palliative (P) | 2017-06-28 | 2017-06-29 | Carboplatin + Etoposide IV 3 day | N | Y | FULVESTRANT + RIBOCICLIB | 100549979 |
| 190006971 | 190004325 | 1.63 | 83 | Curative (C) | 2016-07-25 | 2016-07-30 | Imatinib 200mg | N | N | CEMIPLIMAB | 101199807 |
| 190006979 | 190004326 | 1.84 | 48.4 | Neo-adjuvant (N) | 2017-09-23 | 2017-09-27 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 101171123 |
| 190006986 | 190004327 | 1.83 | 80.3 | null | 2018-05-23 | 2018-05-30 | EW EuroEwing 2012 Arm B VDC/IE | 01 | N | CARBOPLATIN + ETOPOSIDE | 101677995 |
| 190007002 | 190004329 | 1.71 | null | Curative (C) | 2017-09-12 | 2017-09-18 | BLEOMYCIN + CISPLATIN + VINCRISTINE | 02 | Y | CAPECITABINE + OXALIPLATIN | 100555135 |
| 190007006 | 190004330 | 0 | 51.9 | null | 2019-05-08 | 2019-05-13 | PAM x 2 pre-surgery (cycles 1&2) | 02 | N | TRIAL UNSPECIFIED | 101558339 |
| 190007007 | 190004331 | 1.67 | 44 | null | 2018-01-26 | 2018-01-26 | CARBOPLATIN + PACLITAXEL ALBUMIN (ABRAXANE) | 2 | N | CARBOPLATIN + RT | 100173845 |
| 190007012 | 190004332 | 1.74 | null | null | null | 2018-02-09 | GEMCARBO | 01 | null | PACLITAXEL | 100075336 |
| 190007017 | 190004333 | 0 | 68.8 | Palliative (P) | 2013-09-17 | 2013-10-16 | Cisplatin 7 day | 02 | null | CISPLATIN | 101185332 |
| 190007026 | 190004334 | 1.57 | 80 | null | 2019-01-19 | 2019-02-04 | Dinutuximab Beta | N | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101682367 |
| 190007039 | 190004335 | 1.73 | null | Palliative (P) | 2018-05-12 | 2018-05-12 | Cisplatin 7 day | null | null | CISPLATIN | 101850175 |
| 190007040 | 190004336 | 1.85 | null | Curative (C) | 2016-06-22 | 2016-07-12 | null | 02 | Y | CISPLATIN + GEMCITABINE | 101242287 |
| 190007041 | 190004337 | 1.78 | 86.6 | Neo-adjuvant (N) | 2020-08-22 | 2020-09-09 | Carboplatin AUC 2 - 5 | null | null | CARBOPLATIN | 100298617 |
| 190007048 | 190004338 | 1.5 | 35.1 | Palliative (P) | 2019-12-11 | 2019-12-11 | CAPECITABINE + IRINOTECAN | null | null | ECX | 100592254 |
| 190007054 | 190004339 | 1.85 | 61.8 | null | 2019-02-11 | 2019-08-18 | DHAP | 02 | N | GEMCITABINE | 100013421 |
| 190007055 | 190004340 | 1.86 | 41.9 | null | 2019-11-02 | 2020-03-05 | EW EuroEwing 2012 Arm B IE | 02 | null | FLUOROURACIL + IRINOTECAN | 101050437 |
| 190007058 | 190004341 | null | 69 | Neo-adjuvant (N) | 2018-11-20 | 2018-11-23 | CARBOPLATIN + PACLITAXEL | 02 | null | CARBOPLATIN + PACLITAXEL | 100599504 |
| 190007066 | 190004342 | 1.76 | 60.1 | null | 2017-02-07 | 2017-03-08 | EW EuroEwing 99 : VIDE | 01 | N | ETOPOSIDE | 101327755 |
| 190007067 | 190004343 | 1.52 | 34.9 | Palliative (P) | 2019-11-13 | 2020-05-14 | BEAM | null | Y | HYDROXYCARBAMIDE | 101097695 |
| 190007071 | 190004344 | 1.74 | 57 | null | 2017-12-07 | 2017-12-11 | CARBOPLATIN + GEMCITABINE | 02 | Y | CAPECITABINE + OXALIPLATIN | 100010980 |
| 190007073 | 190004345 | null | null | null | 2016-04-16 | 2016-05-12 | CARBOPLATIN + CYCLOPHOSPHAMIDE + ETOPOSIDE | 1 | null | CEMIPLIMAB | 100621110 |
| 190007074 | 190004346 | 1.8 | 70 | Palliative (P) | 2017-10-26 | 2017-11-12 | CISPLATIN + RT | 02 | null | CISPLATIN | 101476057 |
| 190007084 | 190004347 | 1.77 | 78.9 | null | 2019-09-21 | 2019-10-07 | EURAMOS TRIAL | 02 | Y | NIVOLUMAB | 101167734 |
| 190007088 | 190004348 | 1.15 | 79.5 | Palliative (P) | 2018-12-16 | 2019-01-11 | Cisplatin + Etoposide po&iv 3 day | Y | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100680147 |
| 190007089 | 190004349 | 1.51 | 36 | Neo-adjuvant (N) | 2017-04-04 | 2017-04-14 | Cisplatin + Doxorubicin | 02 | N | TRIAL UNSPECIFIED | 101142252 |
| 190007093 | 190004350 | 1.58 | 87.9 | null | 2017-08-27 | 2017-09-20 | OST Euramos 1 Closed Trial - M | 02 | N | LANREOTIDE | 101207122 |